301 related articles for article (PubMed ID: 18274840)
1. Risk factors for biliary tract and ampullary carcinomas and prophylactic surgery for these factors.
Miyazaki M; Takada T; Miyakawa S; Tsukada K; Nagino M; Kondo S; Furuse J; Saito H; Tsuyuguchi T; Chijiiwa K; Kimura F; Yoshitomi H; Nozawa S; Yoshida M; Wada K; Amano H; Miura F; ; ;
J Hepatobiliary Pancreat Surg; 2008; 15(1):15-24. PubMed ID: 18274840
[TBL] [Abstract][Full Text] [Related]
2. Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment.
Kondo S; Takada T; Miyazaki M; Miyakawa S; Tsukada K; Nagino M; Furuse J; Saito H; Tsuyuguchi T; Yamamoto M; Kayahara M; Kimura F; Yoshitomi H; Nozawa S; Yoshida M; Wada K; Hirano S; Amano H; Miura F; ; ;
J Hepatobiliary Pancreat Surg; 2008; 15(1):41-54. PubMed ID: 18274843
[TBL] [Abstract][Full Text] [Related]
3. Whether or not prophylactic excision of the extrahepatic bile duct is appropriate for patients with pancreaticobiliary maljunction without bile duct dilatation.
Kusano T; Takao T; Tachibana K; Tanaka Y; Kamachi M; Ikematsu Y; Nishiwaki Y; Kida H; Waki S; Uchimura M; Furukawa M
Hepatogastroenterology; 2005; 52(66):1649-53. PubMed ID: 16334749
[TBL] [Abstract][Full Text] [Related]
4. Flowcharts for the management of biliary tract and ampullary carcinomas.
Miyakawa S; Ishihara S; Takada T; Miyazaki M; Tsukada K; Nagino M; Kondo S; Furuse J; Saito H; Tsuyuguchi T; Kimura F; Yoshitomi H; Nozawa S; Yoshida M; Wada K; Amano H; Miura F; ; ;
J Hepatobiliary Pancreat Surg; 2008; 15(1):7-14. PubMed ID: 18274839
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic excision of the gallbladder and bile duct for patients with pancreaticobiliary maljunction.
Kobayashi S; Asano T; Yamasaki M; Kenmochi T; Saigo K; Ochiai T
Arch Surg; 2001 Jul; 136(7):759-63. PubMed ID: 11448385
[TBL] [Abstract][Full Text] [Related]
6. Clinical abnormalities in adults with pancreaticobiliary maljunction with and without bile-duct dilatation.
Tanaka K; Nishimura A; Ishibe R; Yoshimine M; Ogata S; Taira A
Can J Surg; 1995 Aug; 38(4):351-4. PubMed ID: 7634202
[TBL] [Abstract][Full Text] [Related]
7. Preferable operative age of choledochal dilation types to prevent patients with pancreaticobiliary maljunction from developing biliary tract carcinogenesis.
Kobayashi S; Ohnuma N; Yoshida H; Ohtsuka Y; Terui K; Asano T; Ryu M; Ochiai T
Surgery; 2006 Jan; 139(1):33-8. PubMed ID: 16364715
[TBL] [Abstract][Full Text] [Related]
8. Pancreatobiliary disorders associated with pancreaticobiliary maljunction.
Kamisawa T; Honda G; Kurata M; Tokura M; Tsuruta K
Dig Surg; 2010; 27(2):100-4. PubMed ID: 20551651
[TBL] [Abstract][Full Text] [Related]
9. S4a + S5 with caudate lobe (S1) resection using the Taj Mahal liver parenchymal resection for carcinoma of the biliary tract.
Kawarada Y; Isaji S; Taoka H; Tabata M; Das BC; Yokoi H
J Gastrointest Surg; 1999; 3(4):369-73. PubMed ID: 10482688
[TBL] [Abstract][Full Text] [Related]
10. Biliary tract cancer accompanied by anomalous junction of pancreaticobiliary ductal system in adults.
Tanaka K; Ikoma A; Hamada N; Nishida S; Kadono J; Taira A
Am J Surg; 1998 Mar; 175(3):218-20. PubMed ID: 9560123
[TBL] [Abstract][Full Text] [Related]
11. Biliary carcinogenesis in pancreaticobiliary maljunction.
Kamisawa T; Kuruma S; Chiba K; Tabata T; Koizumi S; Kikuyama M
J Gastroenterol; 2017 Feb; 52(2):158-163. PubMed ID: 27704265
[TBL] [Abstract][Full Text] [Related]
12. Biliary carcinoma risk in patients with pancreaticobiliary maljunction and the degree of extrahepatic bile duct dilatation.
Kamisawa T; Tu Y; Kuwata G; Egawa N; Nakajima H; Tsuruta K; Okamoto A; Matsukawa M
Hepatogastroenterology; 2006; 53(72):816-8. PubMed ID: 17153430
[TBL] [Abstract][Full Text] [Related]
13. Long-term results of treatment for pancreaticobiliary maljunction without bile duct dilatation.
Ohuchida J; Chijiiwa K; Hiyoshi M; Kobayashi K; Konomi H; Tanaka M
Arch Surg; 2006 Nov; 141(11):1066-70. PubMed ID: 17116798
[TBL] [Abstract][Full Text] [Related]
14. [A survey on the diagnosis and treatment of biliary tract cancers in Shanghai].
Wang BS; Qin J; Deng J; Zhang BH; Han TQ; Shen MC; Rashid A; Hsing AW; Gao YT
Zhonghua Wai Ke Za Zhi; 2005 Apr; 43(7):455-9. PubMed ID: 15854373
[TBL] [Abstract][Full Text] [Related]
15. Status of surgical treatment of biliary tract cancer.
Ishihara S; Miyakawa S; Takada T; Takasaki K; Nimura Y; Tanaka M; Miyazaki M; Nagakawa T; Kayahara M; Horiguchi A
Dig Surg; 2007; 24(2):131-6. PubMed ID: 17446708
[TBL] [Abstract][Full Text] [Related]
16. Biliary tract carcinoma complicating primary sclerosing cholangitis: evaluation with CT, cholangiography, US, and MR imaging.
Campbell WL; Ferris JV; Holbert BL; Thaete FL; Baron RL
Radiology; 1998 Apr; 207(1):41-50. PubMed ID: 9530297
[TBL] [Abstract][Full Text] [Related]
17. Pancreaticobiliary maljunction and carcinogenesis to biliary and pancreatic malignancy.
Funabiki T; Matsubara T; Miyakawa S; Ishihara S
Langenbecks Arch Surg; 2009 Jan; 394(1):159-69. PubMed ID: 18500533
[TBL] [Abstract][Full Text] [Related]
18. Surgical treatment for non-dilated biliary tract with pancreaticobiliary maljunction should include excision of the extrahepatic bile duct.
Hara H; Morita S; Ishibashi T; Sako S; Dohi T; Iwamoto M; Tanigawa N
Hepatogastroenterology; 2001; 48(40):984-7. PubMed ID: 11490854
[TBL] [Abstract][Full Text] [Related]
19. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
20. [Biliary tract carcinomas. I. Gallbladder cancer].
Merdzhanov A; Damianov D; Aleksandrova A; Evtimov G
Vutr Boles; 1981; 20(5):34-9. PubMed ID: 7324451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
